Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Frontiers in Bioengineering and Biotechnology|October 13, 2023
Overview of strategies to improve the antibacterial property of dental implantsShaobo Zhai, Ye Tian, Xiaolu Shi, et al.Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|December 15, 2021
[Preparation and functional identification of human single chain recombinant antibody targeting α-hemolysin of Staphylococcus aureus]Lei Peng, Yingchun Ye, Han Chen, et al.The Journal of Antimicrobial Chemotherapy|September 4, 2023
Imipenem/funobactam (formerly XNW4107) in vivo pharmacodynamics against serine carbapenemase-producing Gram-negative bacteria: a novel modelling approach for time-dependent killingAndrew J Fratoni, Angela V Berry, Xiao Liu, et al.Gels (Basel, Switzerland)|August 28, 2024
Bio-Inspired Photoelectric Dual-Mode Sensor Based on Photonic Crystals for Human Motion Sensing and MonitoringWenxiang Zheng, Zhibin Wang, Mengnan Zhang, et al.International Immunopharmacology|August 15, 2022
EphA2 recognizes Dermatophagoidespteronyssinus to mediate airway inflammation in asthmaZixi Xu, Yingchun Ye, Guoping Huang, et al.Journal of Cancer Research and Clinical Oncology|September 15, 2022
Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancerLulu Zhang, Bo Zhang, Lin Li, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 25, 2022
A novel fully human recombinant antibody neutralizing α-hemolysin of Staphylococcus aureusWenfeng Xu, Lei Peng, Chun Li, et al.Journal of Robotic Surgery|June 19, 2026
Progress and perspectives in soft robotics for surgery and rehabilitationYang Liu, Tianming He, Zheng Yang, et al.Journal of Global Antimicrobial Resistance|July 12, 2022
In vitro and in vivo activities of a novel β-lactamase inhibitor combination imipenem/XNW4107 against recent clinical Gram-negative bacilli from ChinaYun Li, Mengyao Yan, Feng Xue, et al.Journal of Computer-Aided Molecular Design|March 28, 2018
In-silico guided discovery of novel CCR9 antagonistsXin Zhang, Jason B Cross, Jan Romero, et al.Pageof 3